0001213900-21-010577.txt : 20210219
0001213900-21-010577.hdr.sgml : 20210219
20210219161543
ACCESSION NUMBER: 0001213900-21-010577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210219
DATE AS OF CHANGE: 20210219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hochman David P
CENTRAL INDEX KEY: 0001292834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38389
FILM NUMBER: 21655767
MAIL ADDRESS:
STREET 1: 15 WESTON HILL RD.
CITY: RIVERSIDE
STATE: CT
ZIP: 06878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Motus GI Holdings, Inc.
CENTRAL INDEX KEY: 0001686850
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 814042793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 EAST BROWARD BOULEVARD
STREET 2: 3RD FLOOR
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
BUSINESS PHONE: 786-459-1831
MAIL ADDRESS:
STREET 1: 1301 EAST BROWARD BOULEVARD
STREET 2: 3RD FLOOR
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
FORMER COMPANY:
FORMER CONFORMED NAME: Eight-Ten Merger Corp.
DATE OF NAME CHANGE: 20161006
4
1
ownership.xml
X0306
4
2021-02-17
0
0001686850
Motus GI Holdings, Inc.
MOTS
0001292834
Hochman David P
C/O MOTUS GI HOLDINGS, INC., 1301
EAST BROWARD BOULEVARD, 3RD FLOOR
FT. LAUDERDALE,
FL
33301
1
0
0
1
Chairman of the Board
Common Stock, par value $0.0001 per share
2021-02-17
4
A
0
40000
0
A
132114
D
Common Stock, par value $0.0001 per share
2021-02-17
4
A
0
32472
0
A
164586
D
Common Stock, par value $0.0001 per share
2051498
I
By Orchestra BioMed, Inc.
Common Stock, par value $0.0001 per share
110000
I
By DPH 2008 Trust
Common Stock, par value $0.0001 per share
16572
I
By NSH 2008 Family Trust
Stock Option (right to buy)
1.78
2021-02-17
4
A
0
40000
0
A
2031-02-17
Common Stock, par value $0.0001 per share
40000
40000
D
On February 17, 2021, Reporting Person was granted 40,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").
On February 17, 2021, Reporting Person was granted 32,472 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").
Reporting Person is a member of the board of directors of Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person jointly exercises dispositive and voting power over the shares owned by OBIO. Reporting Person disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.
/s/ Andrew Taylor, power of attorney
2021-02-19